Subscribe Sign In Register

Pfizer

2016-10-david-rothnie-rainmakers-alan-schwartz-large.jpg
Portfolio
Alan Schwartz Makes Guggenheim Partners an M&A Player
David Rothnie
October 7, 2016
2016-02-da-oil-prices-drill-large.jpg
Portfolio
Daily Agenda: Oil Prices Fall on Robust Supply
Andrew Barber
August 24, 2016
2016-07-uw-antia-federal-reserve-facade-large.jpg
Portfolio
Daily Agenda: Mixed Signals Complicate Fed Prediction
Andrew Barber
August 22, 2016
Portfolio
U.S. M&A Could Rebound as Companies See Few Other Growth Options
Dan Weil
July 6, 2016
Human Antibody
Portfolio
Investing in a Cure for Cancer
Kaitlin Ugolik
June 7, 2016
Portfolio
Perella Weinberg’s Andrew Bednar Drives Stock Exchange Megadeals
David Rothnie
April 19, 2016
2016-02-david-rothnie-paul-taubman-large.jpg
Portfolio
Takeover Veteran Paul Taubman Aims High with PJT Partners
David Rothnie
January 19, 2016
2015-12-kaitlin-ugolik-healthcare-large.jpg
Corner Office
Investing in the Health Care Revolution
Kaitlin Ugolik
January 4, 2016
2015-12-anne-szustek-deals-of-the-year-allergan-pfizer-large.jpg
Portfolio
Allergan-Pfizer Merger Gives Pharma a Growth Injection
Anne Szustek
December 16, 2015
2015-11-23-da-andrew-barber-venezuela-oil-eulogio-large.jpg
Portfolio
Daily Agenda: Commodity Rout Continues
Andrew Barber
November 23, 2015
2015-10-30-andrew-barber-da-pfizer-large.jpg
Portfolio
Daily Agenda: Liquidity Fuels Continuing M&A Boom
Andrew Barber
October 30, 2015
2015-07-david-rothnie-rainmakers-ben-thorpe-large.jpg
Portfolio
Ben Thorpe Helps Keep Goldman’s Health M&A Franchise in Top Shape
David Rothnie
June 22, 2015